Biotoxtech Co., Ltd. (KOSDAQ:086040)

Biotoxtech Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	17,342	11,370	27,479	12,700	18,592	2,747
Short-Term Investments	12,000	19,000	13,559	17,059	9,559	4,559
Trading Asset Securities	-	2,014	-	1,012	-	13,865
Cash & Short-Term Investments	29,342	32,384	41,038	30,771	28,151	21,171
Cash Growth	-20.38%	-21.09%	33.37%	9.31%	32.97%	113.08%
Accounts Receivable	7,338	7,863	5,355	7,352	5,813	3,802
Other Receivables	333.2	462.71	445.37	158.2	1,055	664.07
Receivables	11,264	9,918	8,392	10,261	8,631	4,949
Inventory	13,032	14,786	11,915	4,454	674.04	835.62
Prepaid Expenses	367.23	423.32	113.14	257.66	202.19	33.53
Other Current Assets	1,638	1,406	3,233	3,387	88.11	188.74
Total Current Assets	55,644	58,918	64,692	49,130	37,746	27,178
Property, Plant & Equipment	56,224	56,516	58,181	58,066	25,409	22,055
Long-Term Investments	10,330	10,320	10,689	10,130	18,373	11,119
Other Intangible Assets	1,581	1,665	1,596	1,483	1,479	1,203
Long-Term Accounts Receivable	-	-	-	-	-	-0
Long-Term Deferred Tax Assets	2,090	1,852	5,344	1,072	565.72	190.43
Long-Term Deferred Charges	-	-	-	-	58.46	116.92
Other Long-Term Assets	2,826	2,093	1,865	819.42	2,110	1,793
Total Assets	133,522	136,191	147,036	125,700	90,741	63,655
Accounts Payable	688.5	673.72	541.98	783.54	815.54	819.28
Accrued Expenses	221.93	183.22	80.5	56	28.1	35.09
Short-Term Debt	43,617	42,818	41,229	27,853	23,843	9,406
Current Portion of Long-Term Debt	5,000	3,750	-	1,000	1,000	4,750
Current Portion of Leases	131.08	165.46	171.03	150.43	199.46	178.79
Current Income Taxes Payable	-	-	-	250.29	48.79	-
Other Current Liabilities	33,042	34,619	33,096	29,435	19,841	10,528
Total Current Liabilities	82,701	82,210	75,119	59,528	45,777	25,718
Long-Term Debt	15,000	16,250	20,000	20,000	1,909	2,825
Long-Term Leases	20.8	65.74	191.59	136.81	97.13	101.52
Other Long-Term Liabilities	110.49	99.68	171.68	161.1	38.12	5.2
Total Liabilities	100,999	101,666	98,801	81,334	48,892	29,373
Common Stock	7,979	7,979	7,979	7,334	7,334	7,313
Additional Paid-In Capital	32,516	32,516	34,125	21,598	21,058	19,973
Retained Earnings	-1,419	58.56	6,740	12,162	9,354	2,428
Treasury Stock	-1,163	-1,163	-165.68	-165.68	-165.68	-165.68
Comprehensive Income & Other	716	691.38	3,032	3,307	3,563	3,978
Total Common Equity	38,629	40,082	51,710	44,235	41,144	33,526
Minority Interest	-6,106	-5,557	-3,475	131.97	705.69	755.92
Shareholders' Equity	32,523	34,525	48,235	44,367	41,849	34,282
Total Liabilities & Equity	133,522	136,191	147,036	125,700	90,741	63,655
Total Debt	63,769	63,049	61,591	49,140	27,049	17,262
Net Cash (Debt)	-34,427	-30,665	-20,553	-18,369	1,102	3,910
Net Cash Growth	-	-	-	-	-71.82%	-
Net Cash Per Share	-2179.86	-1744.94	-1332.10	-1255.03	71.58	267.78
Filing Date Shares Outstanding	15.72	15.72	15.93	14.64	14.64	14.59
Total Common Shares Outstanding	15.72	15.72	15.93	14.64	14.64	14.59
Working Capital	-27,057	-23,292	-10,426	-10,398	-8,031	1,460
Book Value Per Share	2457.20	2549.63	3246.60	3022.26	2811.05	2297.16
Tangible Book Value	37,049	38,417	50,115	42,752	39,665	32,323
Tangible Book Value Per Share	2356.66	2443.71	3146.42	2920.96	2710.03	2214.75
Land	6,668	6,668	6,668	6,668	6,650	4,308
Buildings	51,809	51,808	51,458	51,213	22,710	22,451
Machinery	13,979	13,694	13,203	10,913	4,666	6,257
Construction In Progress	-	65	1.78	131.6	1,654	278.2

Updated Nov 14, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.